Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: The story makes clear the “big unknown” remains the price and “how much people are willing to spend to cut a day or so off of a bout of flu.” The story reports that Genentech, the drug’s manufacturer, said it’s too early to comment on the drug’s U.S. price. The story also notes that in Japan, where the drug was invented, it “sells for the equivalent of about $43.50.” The story uses terms like “a little more than a day” and “nearly a day” and “substantially” to describe the drug’s reduction in flu symptoms, fever, and coughing and sneezing, respectively. It does not explain, as the news release does, that: “Similar efficacy results were seen between baloxavir marboxil and [Tamiflu] in relation to duration of symptoms and fever reduction.” In other words, on the symptom front, both drugs were the same. According to the news release, a difference was seen in the length of time the virus was shed from the body (presumably through coughing and sneezing): 24 hours for baloxavir marboxil verses 72 hours for Tamiflu. The news release also states that there was also a difference seen in the level of virus in the nose and throat, but it provides no precise numbers. It is not known whether this benefit translates into less infection transmission, and the story should have made that clear. The news release issued by Genentech about the FDA’s decision to grant priority review describes baloxavir marboxil’s most common side effects: diarrhea, bronchitis, nausea and sinusitis. The news release also states that overall incidence of adverse events seen in patients taking baloxavir marboxil were lower than those seen in both the placebo group and the group taking Tamiflu. The STAT News story does not mention any potential harms. This evidence comes from the randomized phase III Capstone-1 study the FDA will review, which included 1,436 people in the US and Japan. It excluded people older than 64. The news story does not note this exclusion, nor does it state a key problem with this study: It has never been published in a peer-reviewed journal (instead, a study abstract was released as part of ID Week 2017). This means the full data analysis has never been seen by anyone other than the researchers. We explained why this is important in February 2018, when we discussed news coverage of the drug’s approval in Japan. The 2017-2018 flu season was the worst the US had experienced in nearly a decade. The flu impacted the entire country, and was responsible for 172 pediatric deaths. The news article did not use these or any other flu-related statistics to increase fear about the flu and, in turn, the need for this medication. The article includes two sources: Mark Eisner, Genentech’s VP of product development for immunology, infectious diseases and ophthalmology and Richard Webby, head of the World Health Organization’s influenza collaborating center at St. Jude Children’s Research Hospital in Memphis. Eisner’s affiliation with Genentech, the drug’s manufacturer, is clearly noted. Webby does not appear to have any conflicts of interest. The article would have been stronger if it had included a third source who commented on what–if anything–is known about whether reducing the duration of symptoms leads to reduced levels of transmission that result in fewer people contracting the flu and fewer deaths. The story explains that the only other drug approved to treat the flu is Tamiflu, which is not widely used. The writer explains that both drugs need to be taken within 48 hours of symptom onset and that baloxavir marboxil is a single one-time dose, while Tamiflu must be taken twice daily for five days. It is clear from the story that the FDA is expected to decide by the end of the year whether to approve this new flu medication. The story explains that it’s been more than 20 years since a new class of flu drug has been developed and marketed. (It is available in Japan.) The catalyst for the story was a news release issued by Genentech about the FDA granting priority review of baloxavir marboxil, but the story does not use direct quotes from the news release.

Output: A flu drug — shown to reduce the duration of symptoms — could upend treatment in U.S.


Input: Consider Input: Continental AG announced this week that it has given $5 million to Wildlife Mississippi to finance that organization’s purchase of 1,000 acres along Bayou Pierre west of Hazlehurst in Copiah County. One parcel was purchased from a timber company and one was bought from an individual, said James Cummins, executive director of Wildlife Mississippi The waterway, which empties into the Mississippi River in Claiborne County, is the only home of a fish listed as federally threatened, the bayou darter. Cummins said his group plans to improve habitat by planting native hardwood trees on part of the land which is now planted in pines, and by removing invasive species from areas where there are now hardwoods. The initial restoration work is expected to take place over the winter and spring. Wildlife Mississippi already owns an adjoining 320 acres. “What we’re trying to do is build a larger conservation area around Bayou Pierre,” Cummins said. The stream is plagued by erosion because the channel of the Mississippi is deepening, and Bayou Pierre is carving out a deeper channel of its own to get down to the lower level of the river it feeds into. That’s causing erosion of Bayou Pierre’s banks, harming the stream’s water quality and further stressing the bayou darter. The problem has been going on for years, exacerbated by agriculture and gravel mining in the Bayou Pierre watershed. The U.S. Fish and Wildlife Service has been trying to organize landowners to improve the situation, and Wildlife Mississippi’s entry is one response. Cummins said Wildlife Mississippi was approached by Continental even before the company announced its $1.45 billion tire plant near Clinton in February, and Continental said the transaction was completed in April. “It’s important for Continental to work with local environmental groups to conserve the areas where we’re investing,” Continental Project Manager Grant Bovim said in a statement. Continental ultimately plans 2,500 jobs at the Hinds County site. Wildlife Mississippi will retain the land and is considering public access to the tract in the future. Cummins said the group would like to encourage canoeing and kayaking in Bayou Pierre. ___ Follow Jeff Amy at: http://twitter.com/jeffamy . Read his work at http://bigstory.ap.org/author/jeff-amy .

Output: Tire company gives $5M to protect land around Bayou Pierre.


Input: Consider Input: After Rep. Matt Gaetz (R-Florida) donned a gas mask while Congress debated a bill securing emergency funding to fight the spread of the COVID-19 coronavirus in the United States and beyond, one of his colleagues rebuked both him and an apparent set of double standards.“In 2012, I wore a hoodie on the House Floor to make a statement about the deadly consequences of racial profiling,” Rep. Bobby L. Rush (D-Illinois) wrote on Twitter. “On Wednesday, @RepMattGaetz wore a gas mask in the chamber, making light of an epidemic that has killed 14 Americans. Guess which one of us was forcibly removed.”Rush’s post, which showed photographs of himself alongside Gaetz, was also picked up on Reddit:Rush, a former member of the Black Panthers liberation group who has represented Illinois’ 1st congressional district since 1993, was indeed stopped from speaking and ordered off of the floor on March 28 2012, after revealing that he was wearing a hooded sweater under his blazer in remarks criticizing racial profiling on the part of law enforcement:As soon as Rush removed his jacket and put the hood on his head, Rep. Greg Harper, R-Mississippi, who was presiding over the House floor, began to gavel Rush down, saying he was out of order.Rush ignored him, and with the hoodie still pulled over his head, continued to speak, citing the Bible.Harper continued to bang the gavel. “The gentleman will suspend. The member is no longer recognized,” he said. “The chair must remind members that clause 5 of rule 17 prohibits the wearing of hats in the chamber when the House is in session.”A floor clerk approached Rush as he finished his remarks and led him away from the podium.Afterward, Rush told CNN he was wearing a tie, suggesting he was appropriately dressed for the House floor. He said the purpose of putting on the hoodie was to send a message to young people, “to stand their ground, stand up and don’t stand down.”Rush’s comments came less than a month after the killing of 17-year-old Trayvon Martin in Florida by George Zimmerman, a “community watch” member who claimed that he shot and killed the teen in self defense. Martin’s death was the impetus for nationwide demonstrations, including the “Million Hoodie March” in New York City happening the same day Rush made his remarks:Too often, this violent act that resulted in the violent murder of Trayvon Martin is repeated in the streets of our nation. I applaud the young people all across the land who are making a statement about hoodies [and] about the real hoodlums in this nation. Particularly those who tread on our laws wearing official or quasi-official clothes. Racial profiling has to stop, Mr. Speaker. Just because someone wears a hoodie does not make them a hoodlum.After Rush donned the hood on his sweater, Mississippi Republican and acting Speaker Rep. Greg Harper said, “The gentleman will suspend. The member is no longer recognized.” Harper then ordered an aide to escort Rush from the House floor, citing a rule barring members from wearing coverings on their heads.Martin’s father, Tracy Martin, later commended the lawmaker for his show of solidarity.“My question would be why wasn’t Congressman Rush allowed to address racial profiling. This is something that needs to be talked about,” he said. “This is a country of freedom of speech.”By comparison, Gaetz — a white Republican — was apparently not admonished at all for wearing a gas mask as he and his colleagues voted on the measure allocating $815.2 billion in funding to fighting COVID-19, commonly known as the coronavirus. He later claimed that he was doing so out of concern for his own safety. “Look, members of Congress are human petri dishes,” he said. “We fly through the dirtiest airports. We touch everyone we meet.”As of March 7 2020, more than 225 COVID-19 cases had been diagnosed in the United States, and at least fourteen deaths have been attributed to the disease.It is true that there has been a ban on hats on the floor while the House is in session since 1837. It’s also true that one could make the argument that a gas mask — which covers the face and part of the head — is not a hat. One could also make the same argument about a hoodie. Finally, it’s true that Rep. Bobby Rush was escorted out for pulling a hoodie over his head in 2012, and Rep. Matt Gaetz and his gas mask were allowed to stay in 2020.


Output: While Rep. Matt Gaetz of Florida was allowed to wear a gasmask on the House vote, Democrat Bobby L. Rush was removed from the same grounds for wearing a hoodie.